Ausgabe 3/2020
Inhalt (6 Artikel)
Could the kinetin riboside be used to inhibit human prostate cell epithelial–mesenchymal transition?
Joanna Dulińska-Litewka, Bartosz Gąsiorkiewicz, Aleksandra Litewka, Dorota Gil, Tomasz Gołąbek, Krzysztof Okoń
Silymarin inhibited DU145 cells by activating SLIT2 protein and suppressing expression of CXCR4
Sedat Kacar, Nuriye Ezgi Bektur Aykanat, Varol Sahinturk
Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer
Daniela Gentile, Paola Orlandi, Marta Banchi, Guido Bocci
Primary pulmonary lymphoepithelioma-like carcinoma
Ying Fan, Chenghui Li, Jing Qin, Hongyang Lu
Polypoidal giant cancer cells in metastatic castration-resistant prostate cancer: observations from the Michigan Legacy Tissue Program
Rahul Mannan, Xiaoming Wang, Pushpinder S. Bawa, Daniel E. Spratt, Allecia Wilson, Jeffrey Jentzen, Arul M. Chinnaiyan, Zachery R. Reichert, Rohit Mehra